Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > Cannabidiol (CBD) Market

Cannabidiol (CBD) Market Trends

  • Report ID: GMI4541
  • Published Date: Jun 2024
  • Report Format: PDF

Cannabidiol Market Trends

  • The changing regulatory landscape for the approval of CBD products across various regions is a significant growth driver for the market. As more countries and states adjust their laws to permit the use of CBD for both medicinal and recreational purposes, the market experiences increased demand and investment opportunities.
     
  • Additionally, regulatory bodies are increasingly recognizing the therapeutic potential of CBD, leading to the establishment of clear guidelines and standards for its production, distribution, and sale.
     
  • For instance, in June 2018, the U.S. Food and Drug Administration (FDA) announced its first-ever approval of a cannabis-derived pharmaceutical drug, Epidiolex, an oral solution, approved for the treatment of two rare and severe seizure disorders, Lennox–Gastaut syndrome and Dravet syndrome.
     
  • This regulatory evolution not only enhances consumer confidence but also encourages innovation and the development of new CBD-based products.
     
  • As a result, companies are more willing to enter the market, invest in research, and expand their product portfolios, thereby driving overall market growth.
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global cannabidiol market was valued at USD 22.8 billion in 2023 and is anticipated to witness growth at 17.9% CAGR during 2024-2032, driven by increasing consumer awareness and acceptance of CBD products for their potential health benefits.

The hemp-derived cannabidiol industry accounted for USD 16.2 billion in 2023 and will expand rapidly through 2032, owing to its legal status in many regions.

North America CBD market size was valued at USD 13.6 billion in 2023 and is anticipated to reach USD 63.6 billion by 2032, due to the widespread legalization of cannabis across several states in the U.S. and Canada.

Aurora Cannabis, Charlottes Web, Canopy Growth Corporation, CV Sciences, Inc, Endoca, Elixinol, Folium Biosciencesilray, Gaia Herbs, LLC, GW Pharmaceuticals, and Isodiol International Inc among others.

Cannabidiol Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 17
  • Tables & Figures: 583
  • Countries covered: 22
  • Pages: 340
 Download Free Sample